ETFDH and multiple acyl-CoA dehydrogenase deficiency: The diagnosis of MADD was primarily based on biochemical data (increased levels of acylcarnitines), and confirmed by ETFDH mutation analysis.[5] Although MADD is a treatable disease, it is rare and its diagnosis is difficult due to high clinical heterogeneity.